Kalbe Farma Tbk PT : Group Provides Aid of Medications
August 28, 2017 at 11:33 pm EDT
Share
Press Release No. 028/KFCP-DIR/PR/VIII/17
Jakarta, 25 August 2017 - PT Kalbe Farma Tbk (Kalbe) today handed the aid in form of medications to the victims of fire at Klender area, East Jakarta. The token handover of the aid was given by Franky Dharmawan, Sales Manager of Kalbe Group, to Henny Kasmawati, Chairperson of Family Welfare Empowerment of Klender Sub-District.
'Kalbe is very concerned of the health of those displaced by the fire in Klender,' said Franky Dharmawan, Sales Manager. 'Through this activity, we hope to be able to help the displaced victims of 305 families who are starting to experience numerous illnesses, such as upper respiratory infection (ISPA), diarrhea, hypertension, digestive issues, et cetera.'
Kalbe Shares activities has consistently perform their social responsibility to the community through four pillars: Kalbe Shares Health, which is the base of every social responsibility that is performed; Kalbe Shares Education, by focusing on innovations for healthier Indonesia; Kalbe Shares Environment that commits in guarding a better and healthier environment for a better earth to live in; and Kalbe Shares Infrastructures by placing their concern on supporting infrastructures that increase access and quality of health, education and environment with the principal of building together for a healthier Indonesian communities.
Kalbe at a glance
PT Kalbe Farma Tbk ('Kalbe') was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio; prescription medicines (Cefspan, Brainact, Broadced, etc); over-the-counter medication division (Woods, Promag, Mixagrip, Komix, Fatigon, etc); health drinks (Hydro Coco, Extra Joss, Nitros); nutrition division (ChilKid, Prenagen, Diabetasol, etc); and distribution division. Kalbe currently has more than 20 subsidiaries, 9 production facilities with international standard, and employs more than 17,000 employees dispersed across more than 71 branches throughout Indonesia. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX: KLBF).
--ooOoo--
PT Kalbe Farma Tbk published this content on 25 August 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 August 2017 03:32:05 UTC.
Original documenthttp://www.kalbe.co.id/news-and-events/ArtMID/443/ArticleID/607/Kalbe-Group-Provides-Aid-of-Medications
Public permalinkhttp://www.publicnow.com/view/B112E55C4333FAF607C0AD1AAA63577DA7089B07
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
PT KALBE FARMA TBK. 
